NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 5 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $19,445,085 | +76.4% | 265,100 | +82.7% | 1.00% | +57.2% |
Q3 2022 | $11,025,000 | +76.3% | 145,100 | +61.2% | 0.64% | +75.8% |
Q2 2022 | $6,255,000 | +20.4% | 90,000 | +43.5% | 0.36% | +116.1% |
Q1 2022 | $5,195,000 | -26.2% | 62,700 | -33.2% | 0.17% | -34.1% |
Q4 2021 | $7,043,000 | -5.4% | 93,800 | +46.3% | 0.26% | +12.3% |
Q3 2021 | $7,446,000 | -3.3% | 64,100 | +84.7% | 0.23% | -5.4% |
Q2 2021 | $7,697,000 | – | 34,700 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 63,500 | $3,818,890 | 0.01% |
SIMPLEX TRADING, LLC | 87,600 | $5,268 | 0.01% |
JANE STREET GROUP, LLC | 161,900 | $9,736,666 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |